Form D — Solstice Oncology, Inc.
0002116600-26-000002 · filed Mar 9, 2026
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Check this disclosure on SEC EDGAR · More Biotechnology filings
Offering
- Industry
- Biotechnology
- Exemptions
- Rule 506(b)
- Reported offering amount
- $298,400,851
- Reported amount sold
- $121,260,306
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Solstice Oncology, Inc.
- CIK
- 2116600
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2026
- Address
- 200 BERKELEY ST., 18TH FLOOR
BOSTON, Massachusetts 02116 - Phone
- 617-982-2331
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
CAROLINE LOEW · Executive OfficerBoston, Massachusetts Find on LinkedIn ↗
-
EMILY MINKOW · DirectorBoston, Massachusetts Find on LinkedIn ↗
-
ANDREW LEVIN · DirectorBoston, Massachusetts Find on LinkedIn ↗
-
MORGAN HALLER · DirectorBoston, Massachusetts Find on LinkedIn ↗
-
JULIE GRANT · DirectorBoston, Massachusetts Find on LinkedIn ↗
-
Maiken Keson-Brookes · Executive OfficerBoston, Massachusetts Find on LinkedIn ↗
-
David Feltquate · Executive OfficerBoston, Massachusetts Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗